Covid-19 recovered people showing faster antibody response to Covishield vaccine: Study

Credit: IndiaTimes- Published on March 3, 2021

Video credit: Wibbitz Top Stories
Published on March 2, 2021 -  01:13
Pfizer’s COVID-19 Vaccine May Be Less Effective in Obese People, Study Says
Pfizer’s COVID-19 Vaccine May Be Less Effective in Obese People, Study Says. Researchers in Italy have discovered that the Pfizer/BioNTech vaccine may be less effective in obese individuals. . Their study, which has not been peer reviewed, followed the antibody response caused by two doses of the Pfizer/BioNTech vaccine. In 248 healthcare workers, 99.5 percent were found to have developed an antibody response. . In people who were overweight and obese, that response was found to be blunted. In a separate study of healthcare workers in Brazil, COVID-19 reinfection was more common among people with a higher BMI. Excess body fat can cause metabolic changes such as inflammation and insulin resistance. This constant state of low-grade inflammation can weaken immune responses, which means it’s harder for the body to fight off infection. . Previous research has found that obesity, aka a BMI over 30, increases the risk of dying from COVID-19 by almost 50 percent. . It also increases the risk of being hospitalized with COVID-19 by 113 percent

You are here

💡 newsR Knowledge: Other News Mentions


Disease caused by severe acute respiratory syndrome coronavirus 2
The Vietnamese envoy joins other envoys in getting vaccinated. Earlier this month, Australian envoy got vaccinated using Covishield vaccine.
Credit: DNA - Published 34 minutes ago

Rishi Sunak has been asked to appear before parliament tomorrow to explain why he granted Greensill Capital access to a COVID loan scheme after David Cameron..
Credit: Sky News - Published 1 hour ago

The Haryana government on Monday announced night curfew from 9 pm till 5 am with immediate effect to curb the spike in Covid cases.
Credit: DNA - Published 2 hours ago

Oxford–AstraZeneca COVID-19 vaccine

Vaccine against COVID-19
This is the third COVID-19 vaccine approved by the Subject Expert Committee (SEC) after Covishield and Covaxin.
Credit: DNA - Published 6 hours ago

The safety committee of the European Medicines Agency (EMA) has asked those receiving the AstraZeneca vaccine (called Covishield in India) and medical..
Credit: IndiaTimes - Published 20 hours ago

Related videos from verified sources

Researchers shed light on why COVID vaccine distribution methods fall short 01:41
Credit: ANI - Published on March 2, 2021 

Pfizer Is Studying the Effects of a Third COVID-19 Vaccine Dose 01:05
Credit: Wibbitz Top Stories - Published on February 25, 2021 

High Number of Antibodies After Two Doses of Pfizer Vaccine 01:08
Credit: ODN - Published on February 25, 2021 

You might like